1. Home
  2. AIP vs VSTM Comparison

AIP vs VSTM Comparison

Compare AIP & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arteris Inc.

AIP

Arteris Inc.

HOLD

Current Price

$17.25

Market Cap

677.1M

Sector

Technology

ML Signal

HOLD

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$7.79

Market Cap

723.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIP
VSTM
Founded
2003
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
677.1M
723.8M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
AIP
VSTM
Price
$17.25
$7.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$16.30
$13.38
AVG Volume (30 Days)
518.2K
2.0M
Earning Date
02-17-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,931,000.00
$13,379,000.00
Revenue This Year
$20.67
$208.54
Revenue Next Year
$20.20
$251.40
P/E Ratio
N/A
N/A
Revenue Growth
20.45
33.79
52 Week Low
$5.46
$4.01
52 Week High
$19.85
$11.25

Technical Indicators

Market Signals
Indicator
AIP
VSTM
Relative Strength Index (RSI) 58.26 45.07
Support Level $16.17 $6.68
Resistance Level $17.66 $8.88
Average True Range (ATR) 0.79 0.55
MACD 0.05 0.02
Stochastic Oscillator 84.15 52.73

Price Performance

Historical Comparison
AIP
VSTM

About AIP Arteris Inc.

Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: